TNF inhibitors, in particular, have been associated with an increased risk of serious infections, including reactivation tuberculosis, bacterial sepsis, invasive fungal infections (such as histoplasmosis), and infections due to opportunistic pathogens [27, 28]. The gene discussed is TNF; the disease is fungal infectious disease.